Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08K Sell
15
-18
-55% -$1.7K ﹤0.01% 757
2026
Q1
$3.9K Buy
+33
New +$4.08K ﹤0.01% 674
2025
Q4
Sell
-170
Closed -$24.8K 644
2025
Q3
$24.8K Buy
170
+48
+39% +$7.25K 0.01% 370
2025
Q2
$19.1K Sell
122
-1
-0.8% -$159 0.01% 407
2025
Q1
$20.1K Buy
123
+1
+0.8% +$166 0.01% 407
2024
Q4
$19.8K Hold
122
0.01% 402
2024
Q3
$23.7K Hold
122
0.01% 378
2024
Q2
$20.9K Buy
122
+1
+0.8% +$166 0.01% 405
2024
Q1
$20.2K Buy
121
+1
+0.8% +$187 0.01% 433
2023
Q4
$23.8K Buy
+120
New +$21.2K 0.01% 587

Other funds holding ZTS

Main Street Group's ZTS Position: Q2 2026 in Review

Main Street Group reduced its Zoetis (ZTS) stake by 55% in Q2 2026, selling an estimated $1.7K and leaving 15 shares worth $1.08K. The position accounts for ﹤0.01% of the portfolio, ranked #757.

Main Street Group first reported a position in ZTS in Q4 2023 and has held it in 10 quarters since. The position peaked at $24.8K in Q3 2025. 270 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Main Street Group held 15 shares of Zoetis worth $1.08K as of Q2 2026.
  • Main Street Group sold 18 Zoetis shares in Q2 2026, an estimated $1.7K.
  • Zoetis made up ﹤0.01% of Main Street Group's portfolio in Q2 2026, its #757 holding.
  • Main Street Group first reported a position in Zoetis in Q4 2023 and has held it in 10 quarters since.
  • Main Street Group's Zoetis position peaked at $24.8K in Q3 2025.
  • 270 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.